Thank you to everyone who lent their time and voices to the June 21 committee hearing on the proposal to restrict access to antipsychotic medications through the creation of a Preferred Drug List. Missouri’s mental health advocates sent a clear message and we got results. The Drug Prior Authorization Committee delayed voting and agreed to take time to review the proposals for both of the mental health medication classes listed in the June 21 meeting agenda (antipsychotics and stimulants/ ADHD mediations). NAMI Missouri and the Federation of Behavioral Health Advocates anticipate these issues may come up again at the next quarterly meeting, which is scheduled for September 20. In the meantime, we plan to continue a campaign of education and open dialogue with Mo Healthnet leaders, staff and policymakers. A summary of news coverage garnered by recent events is included below.
St. Louis Post Dispatch: Missouri panel scuttles bid to alter access to mental health drugs